NOVO.B.DK

280.4

-2.2%↓

GMAB.DK

1,552.5

-2.82%↓

HLUNB.DK

42.14

-2.32%↓

ZEAL.DK

284.2

-7.58%↓

AMBUB.DK

62.8

-0.95%↓

NOVO.B.DK

280.4

-2.2%↓

GMAB.DK

1,552.5

-2.82%↓

HLUNB.DK

42.14

-2.32%↓

ZEAL.DK

284.2

-7.58%↓

AMBUB.DK

62.8

-0.95%↓

NOVO.B.DK

280.4

-2.2%↓

GMAB.DK

1,552.5

-2.82%↓

HLUNB.DK

42.14

-2.32%↓

ZEAL.DK

284.2

-7.58%↓

AMBUB.DK

62.8

-0.95%↓

NOVO.B.DK

280.4

-2.2%↓

GMAB.DK

1,552.5

-2.82%↓

HLUNB.DK

42.14

-2.32%↓

ZEAL.DK

284.2

-7.58%↓

AMBUB.DK

62.8

-0.95%↓

NOVO.B.DK

280.4

-2.2%↓

GMAB.DK

1,552.5

-2.82%↓

HLUNB.DK

42.14

-2.32%↓

ZEAL.DK

284.2

-7.58%↓

AMBUB.DK

62.8

-0.95%↓

Search

Coloplast A-S (Class B)

Fechado

378.9 -0.05

Visão Geral

Variação de preço das ações

24h

Atual

Mín

377.6

Máximo

381

Indicadores-chave

By Trading Economics

Rendimento

-2.4B

-971M

Vendas

41M

7.1B

P/E

Médio do Setor

41.674

49.052

EPS

-0.16

Rendimento de Dividendos

5.99

Margem de lucro

-13.707

Funcionários

17,083

EBITDA

2.8B

5.1B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

5.99%

2.36%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.7B

88B

Abertura anterior

378.95

Fecho anterior

378.9

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat